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Abstract
Ferulic acid (FA) and tocopherol (Toc) loaded solid lipid nanoparticles (SLN) were prepared
by a hot homogenisation method. The particle size distribution, zeta potential and melting
behaviour of the SLN as well as the stability, encapsulation efficiency and radical scaveng-
ing activity of FA and Toc in the SLN were analysed. The different formulations containing
up to 2.8 mg g−1 of FA or Toc were stable during at least 15 weeks of storage at room tem-
perature. Despite partial degradation and / or release of FA and Toc during storage, signifi-
cant radical scavenging activity was maintained. DSC measurements and radical
scavenging tests after different time periods revealed that the re-structuring of the lipid
matrix was connected to the enhanced antioxidant activity of Toc but did not affect the activ-
ity of FA.
Introduction
Solid lipid nanoparticles (SLN) have been investigated as carrier systems in pharmaceutical,
cosmetic or food related applications. The potential use of SLN includes the encapsulation of
bioactive compounds, antimicrobials or antioxidants [1]. The encapsulation of antioxidants in
SLN prepared using food grade constituents could be beneficial from both a physiological and
a technological point of view. SLN formulations yielding stable SLN have been widely reported
in the literature, but mainly with a pharmaceutical background, hence also contained non-
food grade materials. Such SLN were demonstrated to be physically stable up to three years
[2]. The solid lipid matrix of SLN has initially been regarded to represent an effective physical
barrier against unfavourable conditions resulting in an increased chemical stability of encapsu-
lated compounds. However, it was reported that the chemical stability of encapsulated com-
pounds depends on the composition of the lipid matrix and the emulsifiers used, as e.g. in the
case of β-carotene [3, 4].
Encapsulation rates near 100% or payloads of 1.1% for lipophilic compounds like tocoph-
erol [5], rosmarinic acid [6] or vitamin A [7] have been reported. For compounds with
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decreasing lipophilicity the encapsulation efficiency decreased, still remaining in the range
of 20 to 26% of the dry matter [8], but values of up to 85% have been reported for the more
hydrophilic ferulic acid [9]. The encapsulation rate is closely related to the composition
of the SLN, i.e. the lipid matrix and the emulsifiers used to stabilise the SLN. The crystallin-
ity of the lipid matrix is among the most important and most investigated properties of
SLN.
Among others, the antioxidant or radical scavenging activity of the encapsulated com-
pounds was investigated in several studies and was assessed in different test systems like rat
brain microsomes [10], cell systems [8] and with different radical initiators like AAPH or t-
BOOH [11] where significant radical scavenging activity was observed. In contrast, SLN
encapsulated co-enzyme Q10 showed negligible reactivity against ABTS [12].
The radical scavenging activity of an encapsulated compound is largely affected by its loca-
tion within the SLN. Comprehensive experiments with different spin probes or curcuminoids
revealed that encapsulated compounds are mainly located at the surface of SLN and that their
location depends on their lipophilicity and the composition of the emulsifier layer [13–16].
The surface of SLN comprises the emulsifiers, i.e. antioxidants may be buried in the emulsifier
layer of SLN. The location within the emulsifier layer has been reported to determine the activ-
ity of antioxidants in micelles, emulsions and SLN [17, 18]. In SLN the solid lipid matrix
undergoes polymorphic transitions directly after preparation and during storage of the SLN.
Due to different packing orders of α, β0 and β polymorphs, polymorphic transitions have been
found to affect the release or activity of the encapsulated compounds [18]. This may be
regarded as shortcoming if a stable formulation with constant properties of prolonged periods
of time is needed. However, the expulsion and / or slow and gradual release of the active com-
pound can also be beneficial e.g. if the antioxidant activity of an encapsulated compound has
to be maintained during extended storage periods.
Ferulic acid (FA) and tocopherol (Toc) are common phenolic antioxidants occurring natu-
rally or being added to food. In the present study these compounds were selected as represen-
tative hydrophilic (FA) or lipophilic (Toc) model compounds for antioxidants relevant to food
applications. Based on their different molecular structures and physico-chemical properties
different encapsulation rates and interactions with SLN were expected.
The aim of this study was to investigate the encapsulation efficiency and the chemical and
physical stability of FA and Toc loaded SLN and how these factors are related to the radical
scavenging activity of the encapsulated antioxidants. Both time and concentration dependent
effects were investigated. Hence, this study contributes to understanding the potential of SLN
as delivery systems for antioxidants in food systems.
Materials & methods
Materials
Glyceryl tristearate (96%, technical grade, TS), polysorbate 20 (< 3% water, Tween201),
trans-ferulic acid (99%, FA), α-tocopherol (96%, Toc) and potassium nitrodisulfate (99%,
Fremy’s salt) were purchased from Sigma Aldrich (Steinheim, Germany). Solvents of the high-
est analytical grade were obtained from Carl Roth, Karlsruhe, Germany. Sodium acetate trihy-
drate was obtained from Merck, Darmstadt. De-oiled soybean lecithin (Epikuron 100 P) and
Ryoto sugar ester S1670 were kind gifts from Cargill, Hamburg, Germany and Harke Food
Tech, Mühlheim, Germany, respectively. All chemicals were used as received without further
purification. Ultrapure water (MilliQ, Millipore) was used throughout the experiments. Unless
stated otherwise solutions and suspensions were prepared using a 0.2 M acetic acid/sodium
acetate buffer solution, pH 5.0.
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Preparation of SLN
SLN were prepared by ultrasound assisted hot emulsification. For each batch of SLN 2.5 g glyc-
eryl tristearate and 125 mg lecithin were mixed and melted by heating to 80˚C under stirring.
The mixture was kept at this temperature for additional 30 min to completely remove possible
crystal memory. Afterwards 7.5 g of a 30.2 ml mL−1 hot aqueous solution of S1670 was added
to the melt. The mixture was emulsified for 30 min by ultrasonic homogenisation using a soni-
cator (Sonopuls HD 3100, Bandelin electronic GmbH, Berlin, Germany) with a titanium tip
(VS70T) applying an amplitude of 75% in pulsed mode with 0.5 s pulse length. During sonica-
tion the temperature was maintained at 80˚C using a thermostatted water bath. The hot emul-
sion was mixed with an equal amount of an aqueous 8% Tween201 solution and cooled
within 1 min to 20˚C under stirring in an ice bath. The final composition of the SLN suspen-
sion was: 5% glyceryl tristearate, 1.35% S1670, 0.25% lecithin and 4% Tween201. All percent-
ages are weight based. Toc or FA loaded SLN (Toc-SLN, FA-SLN) were prepared by dissolving
the appropriate amount of Toc or FA in the hot emulsion before the Tween201 solution was
added. To exclude possible changes in particle size due to the addition of large amounts of
antioxidants, the respective amounts of tristearate were replaced by accurately weighed
amounts of FA or Toc. Final FA or Toc contents in the SLN were between 0.56 mg g−1 and
2.80 mg g−1 of dispersion. Samples were prepared in triplicates in a randomised order and
stored at 25˚C.
Zeta potential and particle size distribution measurements
The zeta potential was measured by electrophoretic mobility of the particles using a ZetaSizer
Nano ZS (Malvern Instruments, UK). Samples were diluted approx. 100 fold with ultrapure
water resulting in a conductivity of 50 ± 5 μS cm−1. The same samples and instrument were
used for the particle size distribution measurements by dynamic light scattering at 25˚C. The
backscattered light was collected at 173˚. The data were evaluated based on the intensity
weighted hydrodynamic diameter (z-average) and polydispersity index (PdI) calculated from
the cumulants analysis. To obtain an insight in the possible presence of several particle popula-
tions number based particle size distributions were obtained from the intensity based particle
size distributions using Mie theory. All measurements were performed in triplicate.
Scanning electron microscopy
Morphological analysis of SLN suspensions was carried out using a QuantaTM 250 FEG-SEM
(FEI, Brno, Czech Republic) equipped with an Everhart-Thornley detector and operated at 10
kV accelerating voltage. The SLN suspension was diluted 1000-fold with 0.2 M sodium acetate
buffer (pH 5.0) and 5 μL was deposited onto silicon substrates and mounted onto aluminium
stubs with double coated carbon conductive tabs.
Extraction of FA or Toc from SLN
For the determination of the total FA or Toc content in the SLN suspension, the following
extraction procedure was applied: 50 mg of the SLN suspension was dissolved in 1 mL of meth-
anol. The solution was heated to 60˚C for 30 min interrupted by three sonication steps in a
sonication bath for 1 min each. Finally, the mixture was centrifuged (10621 g, 40˚C) and the
clear supernatant was transferred into a volumetric flask. A second similar extraction step was
applied and the pooled supernatants were analysed by HPLC. The recovery (%) was calculated
as Rec% ¼ 100 CexCini with Cex being the concentration of extracted FA or Toc and Cini being the
initially added amount of the respective antioxidant. The recovered amount of antioxidants
SLN as carrier systems
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included both, encapsulated and non-encapsulated FA or Toc. All samples were extracted in
duplicates yielding six individual values for each antioxidant and concentration.
Determination of the encapsulation efficiency
The encapsulation efficiency (EE%) was determined by ultrafiltration using centrifugal ultrafil-
tration devices (VivaSpin 2, 300 kDa, Sartorius Stedim Biotech, Göttingen, Germany) that
were pre-rinsed with buffer solution. The filtration units were filled with 1.2 mL of SLN sus-
pension and then centrifuged for 15 min at 5000 g and 25˚C. Filtrate and retentate were
removed and the filtration steps were repeated for a total of 6 times. The membrane was equili-
brated during the first three filtration steps from which the filtrate and retentate were dis-
carded. The concentrations of FA or Toc in the filtrates of steps 4–6 were analysed separately
by HPLC using the same methods as described below. Two independent ultrafiltration devices
were used for each sample yielding a total of 18 individual values for each concentration and
antioxidant. The encapsulated amount was calculated as the difference between the total con-
tent previously determined by extraction, Cex, and the concentration of FA or Toc in the fil-





FA was analysed on an Agilent 1100 system applying the following method: 10 μL of each sam-
ple was injected onto the column (SynergiHydro C18, 4 μm, 150 x 4.6 mm, Phenomenex). The
mobile phase consisted of a mixture of 5% formic acid in water (eluent A) and 5% formic acid
in acetonitrile (eluent B) and was applied at 20˚C and a flow rate of 0.5 mL min−1. The follow-
ing gradient was used to elute the FA: 0 min–100% A, 15 min–100% B. FA was detected by a
DAD at 320 nm. FA concentrations were calculated using a calibration curve linear in the
range from 0.001 mg mL−1 to 0.05 mg mL−1.
Toc was analysed on a Hitachi system (LaChrom Elite, VWR/Hitachi, Darmstadt, Ger-
many) applying the following method: 10 μL was injected onto the column (C30 reversed
phase column, 5 μm, 250 x 4.6 mm, YMC Europe, Dinslaken, Germany). The sample was
eluted with a flow rate of 1 mL min−1 at 27˚C using the following gradient: 0 min–81% metha-
nol, 15% methyl t-butyl ether (MTBE), 4% water; 10 min–72.4% methanol, 23.6% MTBE, 4%
water. Toc was detected by a DAD at 292 nm. Toc concentrations were calculated using a cali-
bration curve that was linear in the range from 0.005 mg mL−1 to 0.05 mg mL−1.
Radical scavenging activity
SLN suspensions were diluted 20-fold with acetic acid buffer solution. A second 2-fold dilution
step was applied by adding 500 μL of 2 mM Fremy’s salt in acetic acid buffer solution to an
equal volume of the diluted SLN suspension yielding final antioxidant and Fremy’s salt con-
centrations of 0.05 mM to 0.3 mM and 1 mM, respectively. The mixtures were allowed to react
for 30 min at 20˚C in the dark. The samples were filled into micropipettes which were then
placed in 0.5 mm quartz tubes. Electron paramagnetic resonance spectroscopy (EPR) measure-
ments were carried out using an e-scan system (Bruker, Rheinstetten, Germany) with the fol-
lowing settings: center field 3482 G, sweep width 150 G, microwave frequency 9.81 GHz,
microwave amplitude 1.83 G, conversion time 10.24 ms. The spectrum of Fremy’s radical was
integrated twice using the software WinEPR (Bruker, Rheinstetten, Germany) [17]. The peak
areas were used to calculate the remaining Fremy’s salt concentrations using a calibration
curve. A second set of measurements was carried out applying different dilution steps to the
SLN suspensions to reach final FA or Toc concentrations of 0.13 mM. The measurements
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were carried out under the same conditions as described above. Two independent measure-
ments were taken for each sample yielding a total of 6 individual values for each concentration
and antioxidant. Linear regression of the concentration of reduced Fremy’s radical vs. antioxi-
dant concentration was performed using the software SigmaPlot 12.3 and slopes and standard
errors were calculated.
X-ray diffraction (XRD) measurements
The samples were concentrated stepwise using centrifugal ultrafiltration devices (VivaSpin 2,
300 kDa, Sartorius Stedim Biotech, Göttingen, Germany) at 4000 g for up to 2 h to increase the
total lipid content. This step did not affect the crystal structure of the samples as revealed by
supporting DSC measurements. XRD measurements were performed on a Bruker D8 Advance
(Bruker AXS, Karlsruhe, Germany). About 600 μL of the concentrated samples was filled into
the round indentation (25 mm diameter, 1 mm depth) of a PMMA sample holder and was
measured in liquid at ambient conditions. The measurements were carried out using Cu
Kα1,2 radiation (λ = 0.15418 nm). Data were collected in the 2θ range of 14˚ to 30˚, with a step
width of 0.24˚ 2θ and 252 s per step applying a position sensitive detector (PSD) Lynxeye. The
background was corrected by subtracting a blank. Differences in the filling heights in the sam-
ple holder resulted in shifts of the diffractograms due to different curvatures of the liquid sur-
face (height error). These shifts were corrected by aligning the first peaks in the diffractograms
with the first peak measured in a dry bulk sample of tristearin. d-values were calculated from
the local maxima of the 2θ-diffractogram by applying Bragg’s-Law: nλ = 2dsin(θ).
DSC measurements
The melting behaviour of blank SLN, FA-SLN and Toc-SLN was analysed by differential scan-
ning calorimetry (DSC, Q2000, TA Instruments, New Castle, USA). Approx. 10 mg of SLN
suspension was transferred into aluminium pans (Tzero) which were then hermetically sealed.
Samples were equilibrated at 25˚C for 5 min and then heated to 80˚C at a rate of 1 K min−1 or
10 K min−1. The thermograms were evaluated using the software TA Universal Analysis 2000
(TA Instruments, Eschborn, Germany) with respect to peak maximum temperature and peak
areas, i.e. melting enthalpy. An empty pan was used as a reference. Two independent measure-
ments were taken for each sample yielding a total of 6 individual values for each particle type
and heating rate.
Statistical analysis
All samples were prepared in triplicates and measurements were performed two to six times as
indicated in the respective sections. Results are presented as means with standard deviations.
Samples were compared by a one sided ANOVA test followed by the Holm-Sidak post-hoc
test using the software SigmaPlot 12.3. Results were considered statistically different with
p< 0.05.
Results and discussion
Particle size distribution and zeta potential
Scanning electron micrographs revealed nearly spherical or ellipsoid particles of 100 nm to
130 nm (Fig 1). The size distributions of the SLN as determined by DLS presented a PdI of
about 0.2, which indicates the existence of a narrow to moderate polydisperse population(Fig
2). The average particle diameter (z-ave) was in the range of 180 nm to 200 nm. The loading of
SLN with FA or Toc did not lead to any substantial changes in particle size distributions
SLN as carrier systems
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(Table 1, Fig 2). Antioxidant concentration dependent variations in particle size were not
expected because the appropriate amounts of tristearate were replaced by the respective anti-
oxidant. In the literature, decreased [9, 12, 19], increased [20–23] and unaffected [8] particle
sizes were observed after loading SLN with different bioactive compounds. These studies
exemplify that the incorporation of compounds into SLN does not necessarily affect the parti-
cle size. Furthermore, the PdI reported in those studies were in the range of 0.05 to 0.31.
Hence, the PdI of the particle size distributions of the present study are well within the range
of values reported in the literature. The non-spherical shape of SLN as depicted in Fig 1 has
been reported earlier and is an effect of the crystal structure of the matrix lipid [16]. This
should be taken into account when interpreting DLS data. Because underlying algorithms
assume spherical particles, DLS might not be sufficiently sensitive to detect small changes or
differences in particle sizes of platelet shaped particles like SLN.
Blank and loaded SLN were stable with respect to the particle size distribution over 15
weeks of storage. Neither the intensity nor the number based particle size distributions
revealed the occurrence of a second population as might be possible by particle aggregation
(Table 1, Fig 2). The high physical stability of SLN at room temperature up to three years has
already been reported in the literature [2] and is one reason for the high interest in this kind of
particles. However, the stability may be impaired by uncontrolled crystallisation behaviour
leading to the gelation of the SLN suspension [24]. The stability of SLN was shown to be tem-
perature dependent with elevated temperatures leading to increased particle sizes [20] or accel-
erated gelation [25]. It was further reported that the stability of SLN was sensitive to the pH
value and ionic strength of the surrounding medium [26]. Thus, in the present study, the aque-
ous phase of the initial suspension (0.1 M sodium acetate buffer solution, pH 5.0) was suitable
to maintain a long term physical stability.
Fig 1. Representative scanning electron microscopy image of FA-SLN. The particle size of the depicted
particles is in the range of 100 to 130 nm.
doi:10.1371/journal.pone.0171662.g001
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Fig 2. Representative intensity and number based particle size distributions of blank SLN, FA-SLN and Toc-SLN at times zero, 6
weeks and 15 weeks.
doi:10.1371/journal.pone.0171662.g002
Table 1. Z-average, polydispersity index (PdI) and zeta potential of SLN directly after preparation and after 6 and 15 weeks of storage, n = 3.
AOxa AOx concn.
mg g−1
Z-Average / nm PDI ZP / mV
Start 6 weeks 15 weeks Start 6 weeks 15 weeks Start 6 weeks 15 weeks
Blank 0 188 ± 18 187 ± 14 180 ± 14 0.232 ± 0.042 0.232 ± 0.033 0.226 ± 0.021 -32.9 ± 4.1 -34.2 ± 0.5 -37.0 ± 1.5
FA 0.55 205 ± 35 183 ± 7 179 ± 6 0.288 ± 0.103 0.205 ± 0.014 0.202 ± 0.014 -25.8 ± 1.4 -35.2 ± 1.7 -38.0 ± 2.3
1.16 172 ± 23 180 ± 17 185 ± 8 0.243 ± 0.035 0.226 ± 0.026 0.205 ± 0.009 -29.6 ± 5.0 -36.0 ± 1.2 -39.8 ± 0.5
1.67 188 ± 20 187 ± 12 183 ± 11 0.207 ± 0.006 0.190 ± 0.024 0.196 ± 0.018 -26.7 ± 1.0 -35.7 ± 0.5 -39.0 ± 0.4
2.19 184 ± 5 180 ± 4 179 ± 4 0.193 ± 0.018 0.184 ± 0.023 0.192 ± 0.012 -28.5 ± 5.9 -35.4 ± 0.3 -39.0 ± 0.9
2.80 177 ± 36 184 ± 29 180 ± 30 0.208 ± 0.026 0.183 ± 0.039 0.181 ± 0.044 -28.0 ± 0.9 -35.2 ± 1.2 -38.5 ± 0.4
Toc 0.56 213 ± 26 205 ± 21 202 ± 22 0.229 ± 0.01 0.201 ± 0.005 0.193 ± 0.028 -28.6 ± 3.6 -36.8 ± 0.5 -38.7 ± 1.4
1.16 204 ± 11 193 ± 6 188 ± 6 0.202 ± 0.02 0.183 ± 0.019 0.196 ± 0.008 -25.6 ± 0.7 -35.9 ± 0.7 -38.2 ± 0.6
1.67 202 ± 4 196 ± 1 191 ± 1 0.199 ± 0.008 0.188 ± 0.025 0.172 ± 0.012 -30.9 ± 2.9 -35.2 ± 0.9 -39.1 ± 0.6
2.19 193 ± 4 190 ± 2 185 ± 1 0.193 ± 0.014 0.166 ± 0.009 0.175 ± 0.022 -30.2 ± 3.8 -35.5 ± 0.0 -39.0 ± 1.0
2.80 216 ± 19 205 ± 36 248 ± 77 0.191 ± 0.021 0.195 ± 0.012 0.255 ± 0.164 -30.9 ± 4.0 -37.2 ± 1.0 -42.9 ± 5.6
a Antioxidant (FA or Toc)
doi:10.1371/journal.pone.0171662.t001
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The zeta potential (ZP) of the SLN as a measure for the surface charge was investigated to
gain more insight into the surface properties related to the loading with antioxidants. The ZP
of the SLN in the present study was in the range of −25 mV to −43 mV (Table 1). It was inde-
pendent of the loading with antioxidants, but increased over time in FA or Toc loaded SLN. In
FA-SLN the ZP increased by about 10 mV during the first 6 weeks of storage and another 5
mV during 9 more weeks. The ZP of Toc-SLN also increased mainly within the first 6 weeks of
storage and in total 10 mV over 15 weeks of storage. It was reported in the literature that the
ZP of SLN remained unchanged upon loading with quercetin [22, 23] or that the ZP of Toc-
SLN was independent of the tocopherol content in another study [5]. However, when particles
were prepared under optimised conditions, Toc-loaded SLN had reduced ZP compared to
unloaded SLN [5]. FA-loaded SLN had about 5 mV higher ZP than the blank SLN [8]. In
another study the ZP of umbelliferone loaded SLN was increased by 40 mV compared to blank
SLN although umbelliferone is a non-ionic molecule [19]. Decreased ZP was observed when
loading SLN with the non-ionic resveratrol or co-enzyme Q10 [12, 21]. The ZP would be
expected to be sensitive to the presence of ionic compounds at the particle surface. FA is nega-
tively charged at pH 5 (pKa = 4.5) [27]. Because the change in ZP was independent of the FA
content in SLN in the present study, it is suggested that either the effect of FA near the surface
was below the detection limit or that the charges were buried in the lipid matrix or the emulsi-
fier layer. Tocopherol as a non-ionic compound was not expected to cause significant changes
in the zeta potential. Nevertheless also the ZP of Toc-SLN increased over time. From this sur-
vey and own data it is concluded that the impact of bioactive compounds on the ZP of SLN
depends more on the molecular structure than the electric charge of the compound. Because
the ZP and its change over time was independent of the type or concentration of antioxidants
in the present study it is suggested that structural re-arrangements near the surface caused the
change in ZP.
Recovery and stability of antioxidants
Directly after preparation the recovery of FA was 87.7% ± 1.7% irrespective of the initial FA
content in the SLN (Table 2). After 15 weeks of storage the average recovery decreased to
82.8 ± 2.6%. In Toc-SLN the average recovery decreased from 77.4 ± 6.7% after preparation to
68.2 ± 6.5% after 15 weeks of storage and decreased with increasing initial Toc concentration.
The initial loss of FA and Toc may have resulted from the elevated temperatures during
particle preparation. To avoid FA or Toc degradation, the respective antioxidant was added






FA 0.56 87.5 ± 2.3 80.6 ± 2.5
1.16 87.8 ± 3.1 82.4 ± 3.9
1.67 88.6 ± 1.8 84.7 ± 0.9
2.19 87.6 ± 1.3 83.7 ± 0.8
2.80 86.9 ± 2.1 82.5 ± 3.6
Toc 0.56 76.9 ± 11.5 79.3 ± 3.7
1.16 80.9 ± 8.6 69.0 ± 2.9
1.67 78.6 ± 1.2 65.4 ± 1.8
2.19 74.6 ± 3.3 63.4 ± 1.0
2.80 75.6 ± 1.1 63.9 ± 2.8
doi:10.1371/journal.pone.0171662.t002
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after homogenisation but before the cooling step. However, to guarantee full dissolution of the
respective compound and its incorporation into the SLN, the hot suspension was stirred for at
least 10 min before the Tween 20 solution was added. Despite the partial degradation of both
antioxidants during particle preparation, they were fairly stable at room temperature. The
recovery rates found in the present study are well within the range of results reported in the lit-
erature. E.g. the recovery of Toc after incorporation into SLN was 75% and increased with
increasing Toc content, while lower recoveries of Toc (66%) were reported in samples stored
at 20˚C for three weeks [5]. In another study, SLN encapsulated Toc was stable for three
months of storage [20]. The influence of the emulsifiers used to stabilise the SLN on the storage
stability of SLN encapsulated β-carotene was demonstrated using lecithins and Tweens. In that
study the stability of β-carotene during storage decreased in the order Tween 80 < Tween
60< high melting lecithin [4]. Hence, the mixture of high melting lecithin and Tween 20 used
in the present study represents a suitable formulation with respect to both, chemical stability
of the encapsulated compounds and physical stability of the SLN.
Encapsulation rates
The initial encapsulation efficiency of FA in SLN decreased with increasing total FA content
from about 80% to 60% which translates into payloads of 0.4 mg g−1 to 1.3 mg g−1 (Fig 3). Dur-
ing storage, FA was partially released into the aqueous phase or micellar pseudophase resulting
in encapsulated proportions between 55% and 45%. The release was concentration dependent
and increased with total FA concentrations. Similar payloads and encapsulation rates for FA
in SLN were reported earlier [8]. These results are in line with the partitioning behaviour of
phenolic compounds in o/w emulsions. Encapsulation efficiencies of FA in 10% corn oil in
water emulsions stabilised by a non-ionic emulsifier were in the range of 60% [27]. Before
cooling, the lipid nanoparticles are hot nanoemulsions so that similar partitioning behaviour is
expected as in o/w emulsions. I.e. the partitioning of a compound between the aqueous phase,
emulsifier pseudophase and lipid phase depends on solubilisation capacities and interactions
with emulsifier molecules [27, 28]. The higher encapsulation rates in the present study may
have resulted from the increased surface area of the SLN compared to the oil droplets in the
emulsions of the mentioned study (approx. 1 μm).
Fig 3. Encapsulation efficiency of FA and Toc in SLN. A) Encapsulated absolute amounts and B) encapsulation rates. Total concentrations on the x-axis
refer to the extracted amounts of FA or Toc. The dataset is available in S1 Dataset.
doi:10.1371/journal.pone.0171662.g003
SLN as carrier systems
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Non-encapsulated tocopherol was below the limit of quantification at each point, i.e. encap-
sulation efficiencies were close to 100% both at the beginning of the experiment and after 15
weeks of storage. This is in good agreement with earlier studies with Toc-SLN of different
composition. Toc-SLN were prepared for the use in sunscreen with a payload of 0.5% w/w
[29]. In another study, the payload of 1.1% Toc was reported to be optimal with respect to par-
ticle size and ZP of the SLN and Toc recovery [5]. Also other lipophilic compounds were
encapsulated in SLN with near to 100% encapsulation efficiencies like vitamin A [7], rosmari-
nic acid [6], quercetin (93%, payload of 0.6%) [22] or co-enzyme Q10 (89%) [12]. Stearyl feru-
late as lipid matrix and the application of washing steps led to lower encapsulation efficiencies
(59%) [10]. Those SLN consisted of stearyl ferulate instead of a triglyceride, and the particles
were washed several times. Tocopherol may have been solubilised by emulsifier micelles and
may therefore have been lost during the washing steps.
With both FA and Toc the encapsulation rates were comparable to literature data reporting
on SLN or emulsions with a triglyceride lipid matrix. The higher encapsulation rate of Toc can
be explained by its higher lipophilicity.
Radical scavenging activity
The radical scavenging activity of the encapsulated antioxidants was followed by the reduction
of Fremy’s salt using EPR spectroscopy. To achieve suitable reaction conditions the SLN sus-
pensions were diluted 40-fold and allowed to react with 1 mM Fremy’s salt. Preliminary exper-
iments revealed that the activity of FA or Toc depended on the total FA or Toc concentration
in the reaction medium but not on the dilution factor (data not shown). In freshly prepared
FA-SLN a near linear reduction of Fremy’s salt with increasing FA concentration was observed
(Fig 4a). A plateau was reached where Fremy’s salt was completely reduced. Therefore, the
region above 1.7 mg g−1 could not be used to interpret time-dependent changes in the radical
scavenging activity of FA-SLN. Linear relationships between Toc concentrations and reduced
Fremy’s salt were observed after each storage period (Fig 4b). The slopes of the linear regres-
sion curves were 1.32±0.14, 1.51±0.20 and 1.58±0.18 at the beginning and after 6 and 15
weeks, respectively.
Fig 4. Radical scavenging activity of FA-SLN (A) and Toc-SLN (B). Samples were analyzsed directly after preparation, 6 weeks and 15 weeks of storage.
SLN were diluted 40-fold resulting in antioxidant concentrations given on the x-axis. The dataset is available in S2 Dataset.
doi:10.1371/journal.pone.0171662.g004
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The reactivity of antioxidants in dispersed systems depends on the location of both radical
and antioxidant in various ways. 1) The reactants must be in close proximity. The emulsifier
layer represents a physical barrier if the solubilisation properties of antioxidants and radicals
differ markedly [17]. 2) The location represents a chemical environment that can be more or
less favourable for the reaction. The local pH value in a micellar system has been demonstrated
to affect the radical scavenging activity of FA [27]. 3) The mobility of the reactants affects their
diffusion and thus the likelyhood of a contact. This was demonstrated to affect the radical scav-
enging activity of Trolox in o/w emulsions [30] or Tocopherol in liposomes [31]. In an earlier
study it was shown that Fremy’s salt was located in the water rich palisade layer in Brij micelles
[17]. It is suggested that Fremy’s radical was located in a region of the SLN surface which is
structurally similar to the palisade layer of non-ionic micelles. It is suggested that time depen-
dent structural rearrangements affected the accessibility of Fremy’s salt for Toc but not for FA.
Crystal structure and melting behaviour
In the present study, solidification of the lipid particles occurred during the very fast cooling of
the suspension to room temperature (approx. 40 K min−1). The crystalline state of the SLN
was studied by XRD.
Freshly prepared blank SLN, FA-SLN and Toc-SLN yielded similar XRD patterns with
reflections at 2θ 19.1˚, 20.2˚, 21.5˚, 22.6˚, and 23.8˚ corresponding to d-values of 4.6 Å, 4.3 Å,
4.1 Å, 3.9 Å and 3.7 Å, respectively (Fig 5). These distances are usually ascribed to the short
spacings of α, β0 and βmodifications of triglycerides [32]. The co-existence of different poly-
morphs and the dependence of their formation on factors like agitation, tempering and the
presence of an emulsifier has been demonstrated e.g. in hydrogenated cotton seed oil [33]. In
the same study, shifts in the short spacings of β0 polymorphs have also been reported. Which
polymorphs were formed in the present study cannot be unambiguously clarified from the
data and would need further investigation. However, the reflections at 21.5˚ and 20.2˚ were
very small indicating that the amount of the respective structures were relatively low. Loading
the SLN with FA or Toc did not interfere with the crystallisation of the tristearin as revealed by
the XRD measurements.
The melting behaviour of blank and loaded SLN was studied using DSC. Melting enthalpies
were in the range of 5.4 J g−1 to 7.7 J g−1 and were inversely proportional to the content of FA
or Toc, i.e. proportional to the triglyceride content of the SLN. The melting enthalpies did not
change over time, indicating that the crystallinity obtained during cooling remained constant
over a storage period of 15 weeks at 25˚C. This result does not match with the ones of other
studies were the addition of Toc and emulsifiers to the lipid matrix led to a reduced crystallin-
ity [5]. However, formulation and process parameters have a strong impact on the crystallisa-
tion of the lipid matrix [34].
The melting range of both blank and loaded SLN was relatively broad, with onset-offset dif-
ferences of about 20˚C (Fig 6). Unloaded SLN heated at 1 K min−1 presented endothermic
peaks at 50˚C, 54˚C and 57˚C and an exothermic peak at 52˚C.
Various authors observed that SLN prepared with monoacid triglycerides and particle size
below 200 nm, as is here the case, show a particular size dependent melting behaviour with
multiple peaks which are not due to polymorphism but to the melting of particles with differ-
ent thicknesses [6, 35–37].
The melting behaviour of triglycerides may undergo more or less important modifications
due to the presence of other components, such as surfactants or encapsulated compounds.
According to Oh and co-workers the addition of up to 5% of sucrose stearate to tristearin exhib-
ited little effect on the α to β transition of tristearin [38]. Other authors observed that the
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presence of 5% of sucrose monostearate hindered the β0 to β transformation [39]. Working
with Tween 20 in concentrations of up to 6% in the suspension, Helgason and co-workers
detected an increase of the number of peaks and a shift to lower temperatures in the melting
transition of tripalmitin as the surfactant concentration in the SLN suspensions increased [40].
In our study however, the most important modification observed was the broadening of the
melting range. Differences in the melting behaviour of loaded and unloaded SLN have also
been reported, e.g. onset, offset and melting temperature were reduced in Toc-SLN as com-
pared to blank SLN [5]. However, according to Bunjes et al. as generally the amount of incorpo-
rated compound is low in relation to the lipid matrix, no pronounced effects are expected [37].
Time and antioxidant concentration dependent changes in the melting behaviour of blank
and loaded SLN were studied using low (1 K min−1) and high (10 K min−1) heating rates in
DSC measurements. During DSC measurements with low heating rates solid-solid transitions
prevail, while with high heating rates melt-mediated transitions do [41]. When heated at 1
K min−1 all SLN showed three distinct sub-peaks both at the beginning of the experiment and
after 15 weeks of storage (Fig 6). When heated at 10 K min−1 the second peak was initially very
broad and the third peak appeared only after 6 or 15 weeks of storage. The different melting
behaviour observed coincides with studies were melt mediated polymorphic transitions
Fig 5. XRD patterns of blank SLN, FA-SLN and Toc-SLN. Peaks were assigned to modifications typically described in the literature. XRD patterns were
scaled to the intensity of the first peak.
doi:10.1371/journal.pone.0171662.g005
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occurred during the measurements at low heating rates [32]. In this case the melting curves
may not reflect the actual state of the solid lipid matrix. The appearance of a more intense peak
at around 56˚C after storage indicates that during storage either the tristearin underwent re-
structuring resulting in an increased proportion of the stable βmodification or that a fraction
of particles increased in size. The latter was not reflected by the DLS measurements. Further-
more, the reduction of the peak at around 50˚C after storage would support the assumption
that the first and third peaks observed could mainly be ascribed to the (α) and (β) modifica-
tions of tristearin.
Although the general trend of the melting profiles was similar for all three SLN types, the
proportion of the observed peaks was different. This was used in an attempt to quantitatively
describe the observed time and concentration dependent changes of the melting behaviour.
Therefore the areas of the sub-peaks obtained with the high heating rate were integrated and
related to the total peak areas (Fig 7).
The assignment of peaks to certain thermal events in complex samples such as the SLN
studied here, is challenging. Therefore the peaks will not be assigned to any polymorphic form
in particular and further in this paper we will refer to peaks 1, 2 and 3.
The relative area of peak 1 was in the range of 0.4 for blank SLN and for FA-SLN irrespec-
tive of the total FA content in SLN or storage time. For Toc-SLN peak 1 showed a relative area
in the range of 0.35 over the entire range of concentrations, while only in SLN with the highest
Toc content, 2.5 mg g−1 Toc, the relative area of this peak decreased significantly after 6 weeks
of storage and then remained unchanged up to week 15. The relative area of peak 2 was in the
range of 0.5 to 0.6 for freshly prepared blank SLN and FA-SLN, irrespective of the FA content.
After 6 weeks the contribution of this peak was reduced almost to the half in blank SLN and in
FA-SLN, remaining unchanged up to 15 weeks. For freshly prepared Toc-SLN the contribu-
tion of peak 2 was slightly higher than for the previous samples, decreasing slowly along the
storage period studied.
Due to the broad melting range of all samples, peak 3 could not be evaluated for freshly pre-
pared samples. After 6 weeks peak 3 presented a relative area of approx. 0.3 for blank SLN and
FA-SLN, remaining unchanged for the rest of the storage period. In the case of Toc-SLN peak
Fig 6. Representative melting curves of loaded and unloaded SLN. Samples were analysed directly after preparation and after 15 weeks of storage
recorded applying heating rates of 1 K min−1 or 10 K min−1. FA or Toc contents in the SLN were 2.8 mg g−1. Vertical lines at 50˚C and 56˚C serve as guides to
the eye.
doi:10.1371/journal.pone.0171662.g006
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3 was evident only after 15 weeks for SLN with low Toc content, while for Toc-SLN containing
1.5 mg g−1 or more Toc the peak was detected already after 6 weeks of storage.
As a result of this evaluation, it can be concluded that the thermal behaviour of blank SLN
and FA-SLN was very similar both just after preparation and along storage. Furthermore,
while these SLN suffered modifications within 6 weeks of storage irrespective of the FA con-
centration, changes in Toc-SLN occurred more slowly and were concentration dependent.
These results suggest that the FA was not incorporated in the lipid matrix while Toc may have
been incorporated or at least been located in close proximity of the lipid matrix.
Proposed location and mechanism
The radical scavenging activities of FA-SLN remained unchanged during the storage period of
15 weeks whereas the activity of Toc-SLN showed time dependent changes. These changes
could neither be explained by changes in encapsulation rates or degradation of the antioxi-
dants during storage. Hence, it is suggested, that changes in the location of Toc and hence the
chemical environment and / or accessibility to Fremy’s salt was responsible for the increased
activity after 6 and 15 weeks of storage. Such structural changes could be reflected by the
changes in the crystal structure and melting behaviour.
Initially the lipid matrices of unloaded and loaded SLN contained, if at all, low amounts of α
and β0 polymorphs. The presence of different polymorphs cannot be unambiguously confirmed.
However, time dependent changes in the melting behaviour reflect structural changes during
storage. If they were related to polymorphic transitions the following point should be addressed:
Packing requirements for the β polymorph are more stringend than for the α or β0 polymorph
[42]. Thus, the α or β0 polymorphs allow for a better encapsulation or incorporation of encapsu-
lated molecules. The crystallisation of the lipid matrix, or the α or β0-to-β transition results in the
expulsion of an encapsulated compound [7, 43–45]. In the present study changes in the melting
Fig 7. Proportions of peak 1, peak 2 and peak 3 in melting curves of SLN containing different amounts of FA (A-C) or Toc (D-F). The dataset is
available in S3 Dataset.
doi:10.1371/journal.pone.0171662.g007
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behaviour were retarded in a concentration dependent manner in Toc-SLN. Time dependent
changes in FA-SLN were similar to blank SLN. Based on these observations we hypothesise that
the different molecular structures and locations of FA and Toc caused the differences in the
melting behaviour. The location of encapsulated compounds, i.e. how much they would be
affected by polymorphic transitions, depends on their molecular structure and solubilisation
properties. With EPR spin probes it was demonstrated that lipophilic compounds were located
in the lipid matrix whereas more hydrophilic compounds were located at the surface of the SLN,
i.e. in the headgroup region of the emulsifiers [13–15]. In o/w emulsions it was found that,
depending on the type of oil phase, emulsifier type and concentration, up to 95% of tocopherol
were located in the emulsifier layer of oil droplets rather than in the droplet core [46]. Hence, we
propose that Toc was located near the lipid matrix of the SLN, probably in the tail region of the
emulsifiers. In contrast, FA is suggested to be located in the outer headgroup regions of the
emulsifier layer at the surface of the SLN. This would explain the stronger impact of Toc on the
(crystal) structure of the lipid matrix. This also implies that Toc was affected more strongly by
structural re-arrangements than FA, because it was in closer contact to the lipid phase.
The impact of Toc on the melting behaviour could either be direct or emulsifier mediated:
If Toc is located in the lipid matrix it could directly affect the melting behaviour and would
directly be influenced by structural re-arrangements. An emulsifier mediated mechanism
would be based on irregularities in the emulsifier chain region caused by tocopherol that in
turn affect the melting behaviour and / or the changed arrangement of emulsifiers upon struc-
tural re-arrangements of the lipid matrix would affected Toc. Both mechanisms seem possible
and their clarification needs further investigation.
Summary and conclusions
It was possible to prepare FA and Toc loaded SLN with payloads up to 2.5 mg/g without signif-
icant effects on particle size distribution and zeta potential. The melting behaviour was affected
by the type and concentration of the antioxidants. Whereas the effect of FA was negligible, the
presence of different amounts of Toc significantly affected time dependent changes in the
melting behaviour. Structural re-arrangements and / or the possible expulsion of Toc from the
SLN increased its radicals scavenging activity. While the activity of FA-SLN was stable over the
entire storage period, the activity of Toc-SLN increased over time. Overall, the SLN and the
antioxidants showed good stability and radical scavenging activity during 15 weeks of storage
at room temperature and may thus be suitable as additives for food systems were a gradual
release of the active compound could be beneficial.
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16. Noack A, Hause G, Mäder K. Physicochemical characterization of curcuminoid-loaded solid lipid nano-
particles. International Journal of Pharmaceutics. 2012; 423(2):440–451. doi: 10.1016/j.ijpharm.2011.
12.011 PMID: 22197758
17. Heins A, McPhail DB, Sokolowski T, Stoeckmann H, Schwarz K. The location of phenolic antioxidants
and radicals at interfaces determines their activity. Lipids. 2007; 42(6):573–582. doi: 10.1007/s11745-
007-3052-6 PMID: 17473943
18. Berton-Carabin CC, Coupland JN, Elias RJ. Effect of the lipophilicity of model ingredients on their loca-
tion and reactivity in emulsions and solid lipid nanoparticles. Colloids and Surfaces A: Physicochemical
and Engineering Aspects. 2013; 431(0):9–17. http://dx.doi.org/10.1016/j.colsurfa.2013.04.016.
19. Lacatusu I, Badea N, Murariu A, Oprea O, Bojin D, Meghea A. Antioxidant activity of solid lipid nanopar-
ticles loaded with umbelliferone. Soft Materials. 2013; 11(1):75–84. doi: 10.1080/1539445X.2011.
582914
20. Dingler A, Blum RP, Niehus H, Müller RH, Gohla S. Solid lipid nanoparticles (SLN (TM)/Lipopearls
(TM))—a pharmaceutical and cosmetic carrier for the application of vitamin E in dermal products. Jour-
nal of Microencapsulation. 1999; 16(6):751–767. doi: 10.1080/026520499288690 PMID: 10575627
21. Gokce EH, Korkmaz E, Dellera E, Sandri G, Bonferoni MC, Ozer O. Resveratrol-loaded solid lipid nano-
particles versus nanostructured lipid carriers: Evaluation of antioxidant potential for dermal applications.
International Journal of Nanomedicine. 2012; 7:1841–1850. doi: 10.2147/IJN.S29710 PMID: 22605933
22. Aditya NP, Macedo AS, Doktorovova S, Souto EB, Kim S, Chang PS, et al. Development and evalua-
tion of lipid nanocarriers for quercetin delivery: A comparative study of solid lipid nanoparticles (SLN),
nanostructured lipid carriers (NLC), and lipid nanoemulsions (LNE). LWT—Food Science and Technol-
ogy. 2014; 59(1):115–121. doi: 10.1016/j.lwt.2014.04.058
23. Bose S, Du Y, Takhistov P, Michniak-Kohn B. Formulation optimization and topical delivery of quercetin
from solid lipid based nanosystems. International Journal of Pharmaceutics. 2013; 441(1–2):56–66.
doi: 10.1016/j.ijpharm.2012.12.013 PMID: 23262430
24. Helgason T, Awad TS, Kristbergsson K, McClements DJ, Weiss J. Influence of polymorphic transforma-
tions on gelation of tripalmitin solid lipid nanoparticle suspensions. Journal of the American Oil Chem-
ists’ Society: 85 (6) 501–511. 2008;85(6):501–511. doi: 10.1007/s11746-008-1219-9
25. Seetapan N, Bejrapha P, Srinuanchai W, Ruktanonchai UR. Rheological and morphological characteri-
zations on physical stability of gamma-oryzanol-loaded solid lipid nanoparticles (SLNs). Micron. 2010;
41(1):51–58. doi: 10.1016/j.micron.2009.08.003 PMID: 19726202
26. Zimmermann E, Müller RH. Electrolyte- and pH-stabilities of aqueous solid lipid nanoparticle (SLN) dis-
persions in artificial gastrointestinal media. European Journal of Pharmaceutics and Biopharmaceutics.
2001; 52(2):203–210. doi: 10.1016/S0939-6411(01)00167-9 PMID: 11522487
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